Recommended First-Line Antiretroviral Therapy Regimens and Risk of Diabetes Mellitus in HIV-Infected Adults in Resource-Limited Settings | Zendy

Ninutcha Paengsai | Zendy; Gonzague Jourdain | Zendy; Nicolas Salvadori | Zendy; Apichat Tantraworasin | Zendy; Jean Yves Mary | Zendy; Tim R. Cressey | Zendy; Romanee Chaiwarith | Zendy; Chureeratana Bowonwatanuwong | Zendy; Sorakij Bhakeecheep | Zendy; Natapong Kosachunhanun | Zendy

Open Access

Recommended First-Line Antiretroviral Therapy Regimens and Risk of Diabetes Mellitus in HIV-Infected Adults in Resource-Limited Settings

Author(s) -

Ninutcha Paengsai,

Gonzague Jourdain,

Nicolas Salvadori,

Apichat Tantraworasin,

Jean Yves Mary,

Tim R. Cressey,

Romanee Chaiwarith,

Chureeratana Bowonwatanuwong,

Sorakij Bhakeecheep,

Natapong Kosachunhanun

Publication year - 2019

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofz298

Subject(s) - medicine , antiretroviral therapy , human immunodeficiency virus (hiv) , diabetes mellitus , intensive care medicine , virology , pediatrics , viral load , endocrinology

Several of the WHO recommended ART regimens, particularly tenofovir + lamivudine +LPV/r and regimens containing efavirenz, may be associated with an increased risk of DM.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research